Histocompatibility Testing

"Histocompatibility Testing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)

Descriptor ID	D006650
MeSH Number(s)	E01.370.225.812.385 E05.200.812.385 E05.478.594.385
Concept/Terms	Histocompatibility Testing Histocompatibility Testing Histocompatibility Testings Testing, Histocompatibility Testings, Histocompatibility Crossmatching, Tissue Crossmatchings, Tissue Tissue Crossmatching Tissue Crossmatchings Tissue Typing Tissue Typings Typing, Tissue Typings, Tissue HLA Typing HLA Typing HLA Typings Typing, HLA Typings, HLA

Below are MeSH descriptors whose meaning is more general than "Histocompatibility Testing".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Immunologic Tests [E01.370.225.812]
Histocompatibility Testing [E01.370.225.812.385]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Immunologic Tests [E05.200.812]
Histocompatibility Testing [E05.200.812.385]
Immunologic Techniques [E05.478]
Immunologic Tests [E05.478.594]
Histocompatibility Testing [E05.478.594.385]

Below are MeSH descriptors whose meaning is related to "Histocompatibility Testing".

Below are MeSH descriptors whose meaning is more specific than "Histocompatibility Testing".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Histocompatibility Testing" by people in this website by year, and whether "Histocompatibility Testing" was a major or minor topic of these publications.

Bar chart showing 74 publications over 26 distinct years, with a maximum of 6 publications in 2004 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	3	3
1997	0	2	2
1998	3	1	4
2000	0	1	1
2002	1	0	1
2003	1	0	1
2004	4	2	6
2005	1	1	2
2006	0	3	3
2007	2	3	5
2008	0	3	3
2009	0	3	3
2010	0	4	4
2011	0	2	2
2012	0	2	2
2013	0	2	2
2014	0	2	2
2015	1	4	5
2016	1	5	6
2017	2	1	3
2018	0	2	2
2019	1	4	5
2020	0	1	1
2021	0	4	4
2022	0	1	1
2024	0	1	1

Below are the most recent publications written about "Histocompatibility Testing" by people in Profiles.

Gandarillas S, Berger A, Stephenson R, Mehregan D, Dasgeb B. Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid. Int J Dermatol. 2025 Feb; 64(2):399-401.

View in: PubMed
Mangum DS, Caywood E. A clinician's guide to HLA matching in allogeneic hematopoietic stem cell transplant. Hum Immunol. 2022 Oct; 83(10):687-694.

View in: PubMed
Ravindranath MH, Filippone EJ, Amato-Menker CJ, Arosa FA, Das B, Ou Y, Norin AJ. Antibodies to cryptic epitopes on HLA class I and class II heavy chains bound to single antigen beads: Clinically relevant? Transpl Immunol. 2021 12; 69:101482.

View in: PubMed
Schoenberg E, Mehregan D, Colombe B, Hazan E, Dasgeb B. The potential role of HLA typing to risk stratify melanoma patients on immunotherapy with associated SJS: pitfalls and opportunities. Int J Dermatol. 2022 09; 61(9):e335-e337.

View in: PubMed
Garcia-Sanchez C, Casillas-Abundis MA, Pinelli DF, Tambur AR, Hod-Dvorai R. Impact of SIRPa polymorphism on transplant outcomes in HLA-identical living donor kidney transplantation. Clin Transplant. 2021 09; 35(9):e14406.

View in: PubMed
Young KA, Ali HA, Beermann KJ, Reynolds JM, Snyder LD. Lung Transplantation and the Era of the Sensitized Patient. Front Immunol. 2021; 12:689420.

View in: PubMed
Garcia-Sanchez C, Usenko CY, Herrera ND, Tambur AR. The shared epitope phenomenon-A potential impediment to virtual crossmatch accuracy. Clin Transplant. 2020 08; 34(8):e13906.

View in: PubMed
Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, G?mez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Salda?a BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Blood Adv. 2019 10 22; 3(20):3123-3131.

View in: PubMed
Filippone EJ, Ravindranath MH. Optimizing HLA-antibody Determination. Transplantation. 2019 07; 103(7):e208.

View in: PubMed
Adler JT, Redfield RR, Kaufman DB, Odorico JS. Isolated pancreas transplantation: Is rank list position related to outcomes of imported grafts? Am J Transplant. 2019 11; 19(11):3124-3130.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement